New Scan-Guided biopsy could catch hidden prostate cancers
NCT ID NCT06923657
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using a special scan (PSMA PET/MRI) to guide prostate biopsies can find cancers that standard methods miss. It includes 230 men with elevated PSA, at least one prior negative biopsy, and low-risk MRI results. The goal is to improve early detection of clinically significant prostate cancer and reduce missed diagnoses.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER SCREENING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Fujian Medical University
RECRUITINGFuzhou, Fujian, 350005, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smarter prostate cancer screening: a blood test that may cut unnecessary biopsies
- Smarter prostate screening: a new risk score aims to cut unnecessary biopsies
- New scan could reveal hidden cancer in High-Risk prostate patients
- Simple blood test could spare prostate cancer patients from unnecessary scans
- New scan could revolutionize prostate cancer monitoring
- New PET scan could outshine CT for kidney cancer staging